CXAI:NASDAQCXApp Inc. Analysis
Data as of 2026-06-13 - not real-time
$0.20
Latest Price
9/10Risk
Risk Level: High
Executive Summary
CXApp Inc. (CXAI) trades around $0.199, essentially flat on its 20‑day SMA (0.199) and modestly above the 50‑day SMA (0.179), indicating a near‑term price equilibrium. The MACD line sits just above its signal (0.0133 vs 0.0124) and the histogram is positive, giving a mild bullish tilt. RSI at 50.2 reinforces a neutral momentum stance. Volume is rising, supporting the price action. On the fundamentals side, the company reports an 86% gross margin but a steep revenue decline of 22% year‑over‑year and operating losses that drive a negative EPS of ‑$0.59. Cash of $12.3 M exceeds debt of $10.9 M, yet operating cash flow remains deeply negative (‑$11.6 M). The stock’s valuation appears cheap relative to book (price‑to‑book 0.72) but expensive on a sales basis (price‑to‑sales 5.0) and it carries no dividend.
Volatility is extreme at 210% over 30 days and beta 2.86 signals outsized market swings, while the historic max drawdown of –87% underscores downside risk. The company’s recent press releases tout new enterprise contracts, a high‑recurring‑revenue mix, and Gartner Visionary recognition, suggesting a potential turnaround in top‑line growth. However, the ongoing cash burn and thin equity cushion (market cap $21.7 M) keep the risk profile high. In this context, the stock is best viewed as undervalued on a balance‑sheet basis but still a high‑risk speculative play. Investors should weigh the upside from the AI‑workplace platform against the near‑term liquidity and profitability challenges.
Volatility is extreme at 210% over 30 days and beta 2.86 signals outsized market swings, while the historic max drawdown of –87% underscores downside risk. The company’s recent press releases tout new enterprise contracts, a high‑recurring‑revenue mix, and Gartner Visionary recognition, suggesting a potential turnaround in top‑line growth. However, the ongoing cash burn and thin equity cushion (market cap $21.7 M) keep the risk profile high. In this context, the stock is best viewed as undervalued on a balance‑sheet basis but still a high‑risk speculative play. Investors should weigh the upside from the AI‑workplace platform against the near‑term liquidity and profitability challenges.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD crossover
- Neutral RSI around 50
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- New enterprise contracts and recurring revenue mix
- Strong gross margin despite revenue dip
- Gartner Visionary recognition boosting market perception
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Strategic positioning in AI‑enabled workplace platforms
- Potential for scaling revenue as AI adoption grows
- Current valuation below book value offering upside
Key Metrics & Analysis
Financial Health
Revenue Growth-22.40%
P/E Ratio-0.3
ROE-100.56%
ROA-31.75%
Debt/Equity68.65
P/B Ratio0.7
Op. Cash Flow$-11612000
Free Cash Flow$-7717125
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI50.2
Support$0.14
Resistance$0.34
MA 20$0.20
MA 50$0.18
MA 200$0.39
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Target Price$1.00
Upside/Downside402.51%
GradeUndervalued
TypeBlend
Risk Assessment
Beta2.86
Volatility210.43%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.